Emergent CEO sold more than $10 million in stock before scrapping J&J COVID-19 vaccine doses: report
Emergent BioSolutions has faced a number of back-to-back PR crises since production issues at its Baltimore facility placed the company under intense scrutiny. The CDMO’s stock price has tumbled as a result, but it appears CEO Robert Kramer cashed out some of his shares just in time. Citing SEC filings, Kramer sold more than $ 10 million worth… Read More »